Cerespir

Immuno-neurology company developing novel treatments for neurodegenerative diseases

placeNew York City, New York, United States calendar_todayFounded 2013 groups5 employees language cerespir.com

Innovation

2 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 113 times.

YearFilings
20231
20241
20252
20261

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon